Management Team

BAS from Stanford, MD from Harvard Medical School and MIT

• Professor of Neurosurgery, Director Surgical Neuro-Oncology at Cedars-Sinai Medical Center
• Numerous patents for immunotherapies and nanotechnologies from his NIH funded laboratory
• Developed 8 new investigational drugs with the FDA and has led numerous clinical trials
• Most recently CEO and Chairman of AcTcell, and Director of Enviro Therapeutics
• Immunology Fellowship at the Institute Pasteur, Paris, Neurosurgery Residency at Massachusetts General Hospital/Harvard

• 25+ year finance and accounting professional 
• Former CFO of Wellness Center USA
• Former Director of Accounting of Second Sight Medical Products, Inc .
• Former Chief Financial Officer of AdvaVet, Inc. and Chief Financial Officer of Solis Tek, Inc.
• CPA in State of California

Professor, Biomedical Sciences and Research in Immunology at Penn/Cedars-Sinai Medical Center

• Leading expert in X-ray crystallography, biophysical, biochemical, and immunology fields, having made significant advances in molecular engineering and cell surface receptors by developing pharmacological agents which include new paradigms in structure-based peptidomimetics drug discovery
• Developed numerous technologies that reverse key mechanisms of immune suppression of cancer

Professor of the Department of Medicine and Director of the Cancer Biology Program at Cedars-Sinai Medical Center

• Fellowship at Vanderbilt University Medical Center Research Director, Oppenheimer Urologic Reference Laboratory (OURLab)
• Holds 6 patents for biomarker detection platforms and stromal targeted therapeutics (inclusive of ENV105 and ENV205)
• Consultant at Xencor Inc. (NASDAQ: XNCR) and Tracon Pharma (NASDAQ: TCON)
• NCI/NIH funded for over 15 years and cited over 11,700 times